Cargando…

Folate Receptor-Targeted Albumin Nanoparticles Based on Microfluidic Technology to Deliver Cabazitaxel

Microfluidic technology (MF) has improved the formulation of nanoparticles (NPs) by achieving uniform particle size distribution, controllable particle size, and consistency. Moreover, because liquid mixing can be precisely controlled in the pores of the microfluidic chip, maintaining high mixing ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Fanchao, Sun, Yating, Lee, Robert J., Wang, Guiyuan, Zheng, Xiaolong, Zhang, Huan, Fu, Yige, Yan, Guojun, Wang, Yifan, Deng, Weiye, Parks, Emily, Kim, Betty Y.S., Yang, Zhaogang, Jiang, Wen, Teng, Lesheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827099/ https://www.ncbi.nlm.nih.gov/pubmed/31623082 http://dx.doi.org/10.3390/cancers11101571

Ejemplares similares

Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy
por: Sun, Yating, et al.
Publicado: (2018)

Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer
por: Qu, Na, et al.
Publicado: (2016)

Microfluidics for nano-drug delivery systems: From fundamentals to industrialization
por: Zhang, Huan, et al.
Publicado: (2023)

Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer
por: Wan, Zhong, et al.
Publicado: (2020)

Preclinical profile of cabazitaxel
por: Vrignaud, Patricia, et al.
Publicado: (2014)

Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation
por: Qu, Na, et al.
Publicado: (2019)

Nanotechnology and Microtechnology in Drug Delivery Systems
por: Sun, Jingyao, et al.
Publicado: (2020)

Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go?
por: Li, Xuefeng, et al.
Publicado: (2022)

Preparation and Study of Folate Modified Albumin Targeting Microspheres
por: Zha, Quanbin, et al.
Publicado: (2022)

Feasibility of cabazitaxel in octogenarian prostate cancer patients
por: Tralongo, Paolo, et al.
Publicado: (2023)

Reduction-Responsive Stearyl Alcohol-Cabazitaxel Prodrug Nanoassemblies for Cancer Chemotherapy
por: Liu, Yuting, et al.
Publicado: (2023)

Critical appraisal of cabazitaxel in the management of advanced prostate cancer
por: Pal, Sumanta Kumar, et al.
Publicado: (2010)

Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors
por: Ferron, Géraldine M., et al.
Publicado: (2013)

New (55)Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging
por: Radford, Lauren L., et al.
Publicado: (2019)

The preparation and characterization of folate-conjugated human serum albumin magnetic cisplatin nanoparticles()
por: Chen, Daozhen, et al.
Publicado: (2010)

Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
por: Yang, Zhaogang, et al.
Publicado: (2019)

Thiophene Derivatives as New Anticancer Agents and Their Therapeutic Delivery Using Folate Receptor-Targeting Nanocarriers
por: Zhao, Menghui, et al.
Publicado: (2019)

Enhanced Uptake and Phototoxicity of C(60)@albumin Hybrids by Folate Bioconjugation
por: Cantelli, Andrea, et al.
Publicado: (2022)

Topical Drug Delivery of Concentrated Cabazitaxel in an α‐Tocopherol and DMSO Solution
por: Sun, Boyang, et al.
Publicado: (2023)

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2011)

Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2016)

Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects
por: Kommineni, Nagavendra, et al.
Publicado: (2019)

Cabazitaxel Induced Thrombotic Microangiopathy in a Patient with Prostate Cancer
por: Nlandu, Yannick, et al.
Publicado: (2019)

TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2019)

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer
por: Pobel, Cedric, et al.
Publicado: (2021)

Olaparib vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2021)

Development of a Plasmonic Sensor for a Chemotherapeutic Agent Cabazitaxel
por: Aşır, Süleyman, et al.
Publicado: (2022)

Folate receptor-targeting mesoporous silica-coated gold nanorod nanoparticles for the synergistic photothermal therapy and chemotherapy of rheumatoid arthritis
por: Li, Xiangyu, et al.
Publicado: (2021)

Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis
por: Zhao, Jinlong, et al.
Publicado: (2017)

Exosomes as smart drug delivery vehicles for cancer immunotherapy
por: Zhang, Huan, et al.
Publicado: (2023)

Cabazitaxel-Induced Stabilization of Microtubules Enhances Radiosensitivity in Ovarian Cancer Cells
por: Kunos, Charles A., et al.
Publicado: (2013)

Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines
por: Machioka, Kazuaki, et al.
Publicado: (2018)

Analysis of cabazitaxel‐resistant mechanism in human castration‐resistant prostate cancer
por: Hongo, Hiroshi, et al.
Publicado: (2018)

Safety and efficacy of cabazitaxel in Japanese patients with castration-resistant prostate cancer
por: Yamamoto, Teppei, et al.
Publicado: (2020)

Continued Androgen Signalling Inhibition improves Cabazitaxel Efficacy in Prostate Cancer
por: Mout, Lisanne, et al.
Publicado: (2021)

Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer
por: James, Nicholas D., et al.
Publicado: (2022)

Assessment of Trends in Second Primary Cancers in Patients With Metastatic Melanoma From 2005 to 2016
por: Deng, Weiye, et al.
Publicado: (2020)

Microfluidic hydrodynamic focusing synthesis of polymer-lipid nanoparticles for siRNA delivery
por: Huang, Xueqin, et al.
Publicado: (2017)

Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles
por: Wang, Haipeng, et al.
Publicado: (2019)

A Novel Isoquinoline Derivative Anticancer Agent and Its Targeted Delivery to Tumor Cells Using Transferrin-Conjugated Liposomes
por: Yang, Xuewei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m3vge1gj0jris8pkoatkrqb4u5